Spruce Biosciences

Filed a patent for "methods and compositions for treating polycystic ovary syndrome" on Fri, August 11, 2023

Filed a patent for "tildacerfont cocrystal formulations" on Wed, May 24, 2023

Filed a patent for "crystalline composition of tildacerfont and methods of use and preparation thereof" on Thu, September 5, 2024

Filed a patent for "methods of treating congenital adrenal hyperplasia" on Thu, August 8, 2024

Filed a patent for "corticotropin releasing factor receptor antagonists" on Thu, October 12, 2023

Filed a patent for "methods and compositions for treating polycystic ovary syndrome" on Thu, September 21, 2023

Filed a patent for "corticotropin releasing factor receptor antagonists" on Thu, December 28, 2023

Filed a patent for "crystalline composition of tildacerfont and methods of use and preparation thereof" on Thu, February 8, 2024

Filed a patent for "methods and compositions for treating polycystic ovary syndrome" on Thu, October 12, 2023

Filed a patent for "crystalline composition of tildacerfont and methods of use and preparation thereof" on Thu, May 25, 2023

Filed a patent for "crystalline composition of tildacerfont and methods of use and preparation thereof" on Wed, May 11, 2022